Metraipolis › archive › dc_71615366e9ec

Cellular therapy in neuromyelitis optica spectrum disorder — Europe PMC PMID:41368361

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41368361
DOI
10.3389/fneur.2025.1709474
License (as archived)
solo-consultazione
Archived
2026-11-08T07:38:02.735Z
SHA-256 of the archived text
fc250bddb729ea8c9dcc5c64e097b5564908f76f3779698ee9c6555bfcb168ac
Stable URL of this page
https://metraipolis.com/documento/dc_71615366e9ec

How to cite

Cellular therapy in neuromyelitis optica spectrum disorder — Europe PMC PMID:41368361 — Europe PMC (en), https://europepmc.org/article/MED/41368361 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_71615366e9ec (Metraipolis archive dc_71615366e9ec, sha256 fc250bddb729ea8c9dcc5c64e097b5564908f76f3779698ee9c6555bfcb168ac)
BibTeX
@misc{dc71615366e9ec,
  title = {Cellular therapy in neuromyelitis optica spectrum disorder — Europe PMC PMID:41368361},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41368361},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_71615366e9ec; sha256 fc250bddb729ea8c9dcc5c64e097b5564908f76f3779698ee9c6555bfcb168ac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41368361. Agents can read the archived copy with the MCP tool read_document.